drugset / Trial / NCT07478328
Chaigui Longmu Ejiao Paste for Ischemic Heart Disease
Phase 2
Not yet recruiting
60 enrolled
Longhua Hospital
DongE E Jiao Coporation Limited · collabShanghai University of Traditional Chinese Medicine · collab
RandomizedParallel-groupDouble-blindTreatment
Summary
This study explores whether Chaigui Longmu Ejiao Paste can reduce the average weekly number of angina attacks in patients with ischemic heart disease after 8 weeks of treatment, using Chaigui Longmu Paste without Ejiao as a parallel control and incorporating a synthesized external control.
Timeline
- Start
- 2026-03-08
- Primary completion
- 2027-03-31
- Completion
- 2028-12-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Chaigui Longmu Ejiao Paste | Unknown | 15 g | Oral |